Malignant tumor tissues exhibit inter-and intratumoral heterogeneities, aberrant
development, dynamic stromal composition, diverse tissue phenotypes, and cell populations …

Realizing the translational impacts of three-dimensional (3D) bioprinting for cancer research
necessitates innovation in bioprinting workflows which integrate affordability, user …

Cancer research depends on the challenging task of producing representative and reliable
models of human disease; these have largely been limited to mouse models or human …

Solid tumors house an assortment of complex and dynamically changing microenvironments
in which signaling events between multiple cell types are known to play a critical role in …

Cancer is characterized by the uncontrolled division of cells, resulting in the formation of
tumors. The tumor microenvironment (TME) consists of a variety of cell types present within a …

The exact mechanistic understanding of cancer metastasis continues to be unknown,
although it is a major cause of death worldwide. Along with the tumor mass, the tumor …

Bioprinting of cell-laden hydrogel constructs providing three-dimensional (3D) spatial
pattern capacity and suitable cellular microenvironment have become essential tools in the …

Next generation engineered tissue constructs with complex and ordered architectures aim to
better mimic the native tissue structures, largely due to advances in 3D bioprinting …

Constant matrix remodeling and cellular heterogeneity in cancer are key contributors to its
development and can profoundly alter treatment efficacy. Developing in-vitro models …

Extrusion bioprinting is a relevant 3D technology to create biological systems in
regenerative medicine, pharmaceutical development and cancer research. Bioink is the …